The daily business briefing: March 19, 2021

European regulators conclude AstraZeneca's vaccine is safe, oil prices fall on concerns about demand, and more

A vaccine vial
(Image credit: BEN STANSALL/AFP via Getty Images)

1. European regulators declare AstraZeneca vaccine safe, effective

The European Medicines Agency has concluded that the coronavirus vaccine AstraZeneca developed with Oxford University is safe despite decisions by several European countries to suspend its use due to suspicions it could be linked to blood clots. The EMA's executive director, Emer Cooke, said the drug regulator had "come to a clear scientific conclusion: This is a safe and effective vaccine." The EMA group found that the vaccine was "not associated with an increase in the overall risk of thromboembolic events, or blood clots," Cooke said, although the agency said it could not definitively rule out a link to a rare blood clotting disorder. Regardless, Cooke said, the vaccine's benefits outweighed any risk.

Subscribe to The Week

Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

SUBSCRIBE & SAVE
https://cdn.mos.cms.futurecdn.net/flexiimages/jacafc5zvs1692883516.jpg

Sign up for The Week's Free Newsletters

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

Sign up
Explore More
Harold Maass, The Week US

Harold Maass is a contributing editor at The Week. He has been writing for The Week since the 2001 debut of the U.S. print edition and served as editor of TheWeek.com when it launched in 2008. Harold started his career as a newspaper reporter in South Florida and Haiti. He has previously worked for a variety of news outlets, including The Miami Herald, ABC News and Fox News, and for several years wrote a daily roundup of financial news for The Week and Yahoo Finance.